We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Continuous Purification Technique Should Significantly Reduce Antibody Production Costs

By LabMedica International staff writers
Posted on 29 Mar 2015
Print article
Image: An Austrian Research Center of Industrial Biotechnology researcher is shown working with a laboratory scale continuous antibody purification reactor (Photo courtesy of the Austrian Research Center of Industrial Biotechnology).
Image: An Austrian Research Center of Industrial Biotechnology researcher is shown working with a laboratory scale continuous antibody purification reactor (Photo courtesy of the Austrian Research Center of Industrial Biotechnology).
An Austrian biotechnology firm has developed a method for the continuous purification of recombinant antibodies from cultures of clarified Chinese hamster ovary (CHO) cells that promises to significantly reduce the production costs of these important therapeutic and research materials.

Investigators at the Austrian Center of Industrial Biotechnology (Graz) replaced batch manufacture of protein A affinity chromatography-purified antibodies with a much simpler and cheaper continuous precipitation method. Currently about 80% of antibody production costs are due to the purification step.

The new precipitation process is based on a cheap mineral salt (CaCl2) and an organic solvent (ethanol). In this system purification of the antibodies depends on calcium-phosphate flocculation with subsequent cold ethanol precipitation in a tubular reactor that is a double-pipe heat exchanger operated in counter-current flow mode.

In a feasibility study that was published in the March 17, 2015, online edition of the Biotechnology Journal the investigators showed that the time from startup until attaining steady state conditions was reached in less than 15 minutes, and both reactors were operated for several hours at steady state without manual intervention, delivering antibody at a constant yield and purity. An overall yield of greater than 90%, with a host cell protein reduction from 42,777 to 9,000 parts per million and a DNA reduction from 359 to 7 parts per million, could be achieved for the antibody investigated. This system enabled cell culture supernatants with low or high antibody titer to be processed with constant reactor size and without changing any parameters or increasing precipitant consumption. Aggregate levels were below 1% under all conditions tested.

"Our method shows great potential as a new platform technology for the pharmaceutical industry," said senior author Dr. Alois Jungbauer, professor of biotechnology and head of bioprocess engineering at the Austrian Centre of Industrial Biotechnology.

Related Links:

Austrian Center of Industrial Biotechnology


New
Gold Member
Pneumocystis Jirovecii Detection Kit
Pneumocystis Jirovecii Real Time RT-PCR Kit
Unit-Dose Packaging solution
HLX
New
Laboratory Electric Thermostat
DNP-9025A
New
ELISA System
ABSOL HS DUO

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: The bowel cancer breakthrough could result in better treatment outcomes (Photo courtesy of 123RF)

New RNA Molecules Can Help Predict Bowel Cancer Return Recurrence

Colorectal cancer accounts for 10% of all cancer-related deaths worldwide and was ranked as the second most common cause of cancer death in the United States in 2022. Currently, clinicians face diagnostic... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Microbiology

view channel
Image: The InfectoSynovia test has the potential to revolutionize the diagnosis of periprosthetic joint infection (Photo courtesy of 123RF)

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Periprosthetic joint infection (PJI) represents a significant global issue that is worsening as the number of joint replacements increases due to aging populations. In the United States alone, the anticipated... Read more

Pathology

view channel
Image

AI-Based Method Shows Promise for Pathological Diagnosis of Hereditary Kidney Diseases

Alport syndrome is a hereditary kidney disorder characterized by kidney dysfunction, sensorineural hearing loss, and ocular abnormalities. Early in the disease, patients experience hematuria, which is... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.